Add this topic to your myFT Digest for news straight to your inbox
For a biotech with a tiny free float, shrinking revenues and mounting losses, liquidity might not be the big issue
Pharma company’s shares return to trading after self-inflicted insolvency
Biotech was supported by Liverpool council but fell victim when funds were cut
Chamberlin has been battling against the odds and competition since 1890
Liverpool local authority says drug company missed repayment deadline for £2m loan
Research company plans to build on wizards of Alderley
UK life science industry shows sign of life beyond southeast
Liverpool biotech backed by owner of failed parcel-delivery group City Link eyes Aim flotation
International Edition